Publisher’s Take note: MDPI stays neutral regarding jurisdictional promises in released maps and institutional affiliations. Summary Tirzepatide is a fresh molecule capable of managing glucose blood amounts by combining the dual agonism of Glucose-Dependent Insulinotropic Polypeptide (GIP) and Glucagon-Like Peptide-one (GLP-1) receptors. GIP and GLP1 are incretin hormones: These are https://griffineyoes.shotblogs.com/this-article-is-under-review-42129971